Skip to main content
Fig. 2 | BMC Endocrine Disorders

Fig. 2

From: Nivolumab-induced thyroid dysfunction lacking antithyroid antibody is frequently evoked in Japanese patients with malignant melanoma

Fig. 2

Overview of thyroid immune-related adverse events (irAEs) in patients with melanoma treated with nivolumab

The continuous levothyroxine replacement was needed in two out of three hypothyroid patients who had preceding transient thyrotoxicosis and in only one out of four hypothyroid patients without preceding thyrotoxicosis.

Abbreviations: irAE, immune-related adverse event

Back to article page